Document is current
Any future updates will be listed below
-
Authors
Francis, Jynfiaf https://orcid.org/0000-0003-2164-6145
Tsiartas, Panagiotis https://orcid.org/0000-0002-1785-8535
Hreinsson, Julius https://orcid.org/0000-0001-9073-8313
Andersson, Maria https://orcid.org/0000-0003-0005-7114
Hermansson, Jonas https://orcid.org/0000-0002-1091-5576
Gogas, Periklis https://orcid.org/0000-0002-5134-3869
Papadimitriou, Theophilos https://orcid.org/0000-0001-9035-183X
Kärrberg, Cecilia https://orcid.org/0000-0002-6286-1733
Brännström, Mats https://orcid.org/0000-0002-6081-9101
Akouri, Randa https://orcid.org/0000-0001-5524-0165
-
Funding
Funding for this research was provided by:
Gedeon Richter
Ferring Pharmaceuticals
Stiftelsen Handlanden Hjalmar Svenssons (HJSV 2024053)
University of Gothenburg
- License Information
-
More Information
Article History
Received: 28 February 2025
Accepted: 5 May 2025
First Online: 22 May 2025
Declarations
:
: Ethical approval was obtained from the Swedish Ethical Review Authority (Dnr 2022–03339-01 and 2023–04431-02). The study’s aims were carefully explained to participants to ensure informed consent, with written consent obtained from all participants.
: The authors declare no competing interests.
